Conclusion
fractures, bone loss
BONE LOSS
In conclusion, our results revealed that a single administration of zoledronic acid may ameliorate the bone loss at the lumbar spine and whole body and maintain the subperiosteal diameter, endocortical diameter, and CSMI as parameters of bone strength at the narrow neck in post-transplant patients during 6 months of follow-up. However, Further research is required, particularly to assess the long-term impact of bisphosphonates in preventing fractures, before their prophylactic usage after kidney transplantation can be widely recommended.
